Cite

HARVARD Citation

    Arndt, C. et al. (2014). Redirection of CD4+ and CD8+ T lymphocytes via a novel antibody‐based modular targeting system triggers efficient killing of PSCA+ prostate tumor cells. Prostate. 74 (13), pp. 1347-1358. [Online]. 
  
Back to record